Veerhealth Care Ltd Q3 FY26 results press release summary

Results press release of 16 Feb 2026, summarised by AI from the filing.

Veerhealth Care reports Q3 FY26 Total Income ₹6.96 cr (YoY growth 73.13%) and Net Profit ₹0.40 cr (YoY growth 474.18%).

Key takeaways

1. FY27 guidance Expecting Total Revenues of ₹45-50 cr with PAT of 7-10%.
2. US FDA clearance Received US FDA clearance, enabling exports of Drug (OTC) products to the USA and unlocking access to other international markets.
3. Export growth Growth in Export Sales and addition of new product categories bolstered position in global and local markets.
4. Forward-looking risks Statements subject to risks like government actions, political or economic developments, technological risks.

Original filing on BSE

Veerhealth Care Ltd earnings call, investor presentation and press release summaries

• Q4 FY26: Results press release (2 Jun 2026)
• Q3 FY26: Results press release (16 Feb 2026)
• Q1 FY26: Results press release (13 Aug 2025)
• Other events: Strategy deck (27 Jun 2026), Strategy deck (25 Feb 2026)